Michael Patrick Miller, EVP, US Commercial at Jazz Pharmaceuticals plc (JAZZ), sold 200 shares at $139.99 ($28K) on 2018-02-14, disclosed to the SEC on 2018-02-16.
Scheduled sale ($28k) by EVP, US Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PBYI | SELL | 2023-11-09 | $71K | — | Filing → |
| PBYI | SELL | 2023-06-15 | $47K | — | Filing → |
| PBYI | SELL | 2022-08-10 | $89K | — | Filing → |